Ladenta Pharmaceuticals Private Limited
About Ladenta Pharmaceuticals Private Limited
Data last updated:
Ladenta Pharmaceuticals Private Limited was a private limited company based in Gurgaon, Haryana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 December 2012.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U85100HR2012PTC047898. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors Prashant Dagar and Savita Devi.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 344/3 Prem Nagar Sector – 12A, Gurgaon, Haryana, India – 122001.
Company details
Contact details
Ladenta Pharmaceuticals Private Limited's registered office is in Gurgaon, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address344/3 Prem Nagar Sector – 12A, Gurgaon, Haryana, India – 122001
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Ladenta Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ladenta Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Ladenta Pharmaceuticals Private Limited
FY 2018 filings availableLadenta Pharmaceuticals Private Limited reported revenue of ₹4,032 for FY 2018.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ladenta Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ladenta Pharmaceuticals Private Limited
Ladenta Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Dagar | Director | 13 Dec 2012 | 13 Years 10 Months | As last reported |
| Savita Devi | Director | 20 Oct 2014 | 12 Years 0 Months | As last reported |
Auditor
Ladenta Pharmaceuticals Private Limited is audited by SANJEEV KAVISH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJEEV KAVISH & ASSOCIATES | FY 2017 | 014134N |
Shareholding
The shareholding of Ladenta Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Ladenta Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ladenta Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ladenta Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ladenta Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ladenta Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ladenta Pharmaceuticals Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Parveen Singh ceased to be Director on 20 Oct 2014.
Frequently asked questions
Ladenta Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Ladenta Pharmaceuticals was a private limited company based in Gurgaon, Haryana, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 December 2012 and is registered under CIN U85100HR2012PTC047898. The company has been struck off by the Registrar of Companies and is no longer operational.
Ladenta Pharmaceuticals had 2 directors:
- Prashant Dagar - Director
- Savita Devi - Director
The CIN (Corporate Identification Number) of Ladenta Pharmaceuticals is U85100HR2012PTC047898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ladenta Pharmaceuticals is at 3443 Prem Nagar Sector – 12A, Gurgaon, Haryana, India – 122001.
Ladenta Pharmaceuticals was incorporated on 13 December 2012. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Ladenta Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
No. Ladenta Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Ladenta Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
Parveen Singh ceased to be Director on 20 Oct 2014. Savita Devi was appointed as Director on 20 Oct 2014. Prashant Dagar was appointed as Director on 13 Dec 2012.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
